Case studyMedTech

Regulatory Strategy for 510(k) Clearance and Successful US Market Entry

An international MedTech manufacturer

An international MedTech manufacturer was preparing to enter the US market on a fixed timeline and had no experience with FDA requirements. Entourage developed the regulatory strategy for the 510(k) clearance.

The challenge

The situation

A fixed timeline put the timely product launch at risk, while a lack of experience with FDA requirements created uncertainty. Open items in the CE documentation added further delay, and unclear clinical evidence complicated the marketing claims.

Our approach

What we delivered

Classifying the product to confirm the 510(k) clearance pathway

Managing the integration of the EU documentation through a gap analysis

Coordinating with the FDA to clarify marketing claims via the Q-Sub process

Project management: scheduling and resource alignment for the 510(k) approach

The outcome

Results & impact

510(k) pathway confirmed

Classifying the device confirmed the 510(k) premarket notification as a viable clearance route.

Marketing claims clarified with the FDA

The Q-Sub process established up front which claims the available clinical evidence supports.

Market entry within the timeframe

Entry into the US market took place within the set timeframe, with no delay in the process.

In summary

Entry into the US market took place within the set timeframe.

Regulations & standards considered

FDA 510(k) Premarket Notification (21 CFR Part 807)

Related expertise

FDA Clearance & Approval →

510(k) clearance pathway and US market entry for medical devices

Health Authority Interaction →

Alignment with the FDA, for example via the Q-Sub process

Regulatory Affairs →

Regulatory strategy, classification, and documentation

CE Marking →

EU documentation as the basis for the US clearance pathway

Similar projects

Design Transfer of Combination Products from Development to Production

A medical device company with combination products needed to make the design transfer from development to production more efficient while overcoming regulatory hurdles under the EU MDR and the FDA.

MedTech

Design-to-Scale-up: Processes for Scalable Growth

Insufficiently prepared business realization processes held back growth and efficiency in the attempt to scale operations.

MedTech

Improving Overall Supply Chain Effectiveness at a Medical Device Manufacturer

Optimizing overall supply chain effectiveness at a medical device manufacturer, from demand planning and supplier management through to inventory control.

Sources

https://theentourage.de/case-study/fda-510k-market-clearance/ (live case study, accessed 2026-06-14)

Your project

A comparable project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
info@theentourage.de

Reply usually within one working day
4 offices: DE · CH · IT · US
100% life sciences